APP下载

难治性肾病综合征并发尿路感染的病原菌分布与耐药性分析

2015-01-31杨亚娜

中国继续医学教育 2015年2期

【摘要】目的 分析难治性肾病综合征并发尿路感染的病原菌分布与耐药性,为临床合理治疗提供依据。方法 选取2011年10月~2014年6月于本院进行治疗的88例肾病综合征并发尿路感染患者,采集患者尿液标本进行病原学培养及药敏试验,分析病原菌分布特点与耐药性。结果 大肠埃希菌比例显著高于其它病原菌,P<0.05,差异具有统计学意义。大肠埃希菌对氨苄西林的耐药性显著高于其它抗生素,P <0.05,差异具有统计学意义。结论 难治性肾病综合征并发尿路感染的最常见病原菌是大肠埃希菌,对氨苄西林有较高的耐药性,临床应根据药敏结果合理应用抗生素进行治疗。

doi: 10.3969/j.issn.1674-9308.2015.02.112

作者单位:114000 鞍山,鞍钢集团总医院肾内科

The Analysis on Pathogen Distribution and Drug Resistance of Refractory Nephrotic Syndrome With Urinary Tract Infection

YANG Yana ( Department of Internal Medicine, General Hospital of Anshan Iron and Steel Group, Anshan 114000, China )

[Abstract] Objective To analyze the pathogen distribution and drug resistance of refractory nephrotic syndrome with urinary tract infection, and to provide evidences for clinical rational treatment. Methods From October, 2011 to June, 2014, 88 patients with refractory nephrotic syndrome with urinary tract infection were selected in our hospital. Urine specimens were collected from patients and made pathogen culture and drug sensitivity test. The pathogen distribution characters and drug resistance were analyzed. Results Escherichia coli were markedly higher than the other pathogens, P<0.05, there was significant difference. The drug resistance of Escherichia coli to ampicillin was significantly higher than other antibiotics, P<0.05, there was significant difference. Conclusions The most common pathogen of refractory nephrotic syndrome with urinary tract infection was Escherichia coli. Its drug resistance was high to ampicilli. Antibiotics should be applied reasonably according to the drug sensitivity results.

[Key words] Refractory nephrotic syndrome, Urinary tract infection, Pathogen distribution, Drug resistance

尿路感染是肾病综合征最常见的并发症之一 [1],尿路感染的发生与机体的免疫力低下和长期的激素应用有关 [2-3]。本研究就难治性肾病综合征并发尿路感染的病原菌分布与耐药性进行研究和探讨,现总结如下。

1 资料与方法

1.1 一般资料

选取2011年10月~2014年6月于本院进行治疗的88例肾病综合征并发尿路感染患者,采集患者尿液标本进行病原学培养和分离,分析病原菌分布特点与耐药性。88例患者中,男性37例,女性51例;年龄10~68岁,平均年龄(37.5±4.2)岁;其中肾病综合征初发患者38例,复发患者50例;其中46例患者伴有尿频、尿急、尿痛等尿路感染症状,42例患者无尿路感染相关症状。

1.2 方法

所有患者均进行尿液病原菌培养分离及药敏试验。

1.3 评价标准

真性细菌尿:若患者有尿路感染症状,导尿行尿液细菌培养,细菌数量≥10 5/ml;……

登录APP查看全文